Friday Pipeline Update: Three deals file as pipeline begins to awaken
NEW FILINGS Company: Contineum Therapeutics, Inc. Symbol: CTNM (Nasdaq) Description: They are a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Shares: TBD Price Range:[…]
